Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A

OncoTargets and Therapy 2023, 16:215-225

Published Date: 1 April 2023